Scatterplot 2. by Chao Yang (174810)

“…When the HAR was at a low level, mortality within 28 days after ICU admission decreased significantly as the HAR increased. …”

Raw data of this study. by Chao Yang (174810)

“…When the HAR was at a low level, mortality within 28 days after ICU admission decreased significantly as the HAR increased. …”

Scatterplot 4. by Chao Yang (174810)

“…When the HAR was at a low level, mortality within 28 days after ICU admission decreased significantly as the HAR increased. …”

Scatterplot 3. by Chao Yang (174810)

“…When the HAR was at a low level, mortality within 28 days after ICU admission decreased significantly as the HAR increased. …”

Correlation matrix. by Chao Yang (174810)

“…When the HAR was at a low level, mortality within 28 days after ICU admission decreased significantly as the HAR increased. …”

Scatterplot 7. by Chao Yang (174810)

“…When the HAR was at a low level, mortality within 28 days after ICU admission decreased significantly as the HAR increased. …”

Deactivation mechanism of catalyst in long-period experiment of 1,1,2-TCE dehydrochlorination by Xiang Ge (7326497)

“…The results indicated that the catalyst life had been significantly improved. In the early stage of the reaction, the activity of the catalyst decreased rapidly. …”

Table 2_Nitric oxide regulates photosynthesis and the capacity of the antioxidant system under water deficit and rehydration in Lolium multiflorum/Festuca arundinacea introgression... by Dawid Perlikowski (648680)

“…The obtained results clearly indicated a higher photosynthetic capacity of the plants with a decreased NO content on the 12th day of water deficit (12% of soil water content), which was manifested by a higher CO₂ assimilation level. …”

Table 1_Nitric oxide regulates photosynthesis and the capacity of the antioxidant system under water deficit and rehydration in Lolium multiflorum/Festuca arundinacea introgression... by Dawid Perlikowski (648680)

“…The obtained results clearly indicated a higher photosynthetic capacity of the plants with a decreased NO content on the 12th day of water deficit (12% of soil water content), which was manifested by a higher CO₂ assimilation level. …”

Figure 6 from PD-1 Blockade Mitigates Surgery-Induced Immunosuppression and Increases the Efficacy of Photodynamic Therapy for Pleural Mesothelioma by Gwendolyn M. Cramer (16964052)

“…<b>C,</b> In AB12 tumor–bearing mice that received TI prior to PDT, αPD-1 significantly decreased the rate of tumor regrowth (<i>P</i> = 0.005), with a median survival >90 days for TI/PDT/αPD-1 (<i>n</i> = 13) and 24-day median survival in TI/PDT (<i>n</i> = 16). …”

Data Sheet 5_Global, regional, and national burdens of congenital heart anomalies from 1990 to 2021, and projections to 2050.pdf by Erdengqieqieke Ye (19542808)

“…Correlation analysis revealed increasing trends of prevalence and YLDs with rising SDI, while incidence, deaths, DALYs, and YLLs demonstrated a declining trend with SDI elevation. From 2022 to 2050, the prevalence of congenital heart anomalies is projected to rise significantly, especially in the 0−4 age group, while mortality rates are expected to continue a slow downward trend, particularly in the 20−69 age group.…”

Data Sheet 9_Global, regional, and national burdens of congenital heart anomalies from 1990 to 2021, and projections to 2050.pdf by Erdengqieqieke Ye (19542808)

“…Correlation analysis revealed increasing trends of prevalence and YLDs with rising SDI, while incidence, deaths, DALYs, and YLLs demonstrated a declining trend with SDI elevation. From 2022 to 2050, the prevalence of congenital heart anomalies is projected to rise significantly, especially in the 0−4 age group, while mortality rates are expected to continue a slow downward trend, particularly in the 20−69 age group.…”

Data Sheet 6_Global, regional, and national burdens of congenital heart anomalies from 1990 to 2021, and projections to 2050.pdf by Erdengqieqieke Ye (19542808)

“…Correlation analysis revealed increasing trends of prevalence and YLDs with rising SDI, while incidence, deaths, DALYs, and YLLs demonstrated a declining trend with SDI elevation. From 2022 to 2050, the prevalence of congenital heart anomalies is projected to rise significantly, especially in the 0−4 age group, while mortality rates are expected to continue a slow downward trend, particularly in the 20−69 age group.…”

Data Sheet 10_Global, regional, and national burdens of congenital heart anomalies from 1990 to 2021, and projections to 2050.pdf by Erdengqieqieke Ye (19542808)

“…Correlation analysis revealed increasing trends of prevalence and YLDs with rising SDI, while incidence, deaths, DALYs, and YLLs demonstrated a declining trend with SDI elevation. From 2022 to 2050, the prevalence of congenital heart anomalies is projected to rise significantly, especially in the 0−4 age group, while mortality rates are expected to continue a slow downward trend, particularly in the 20−69 age group.…”

Data Sheet 8_Global, regional, and national burdens of congenital heart anomalies from 1990 to 2021, and projections to 2050.pdf by Erdengqieqieke Ye (19542808)

“…Correlation analysis revealed increasing trends of prevalence and YLDs with rising SDI, while incidence, deaths, DALYs, and YLLs demonstrated a declining trend with SDI elevation. From 2022 to 2050, the prevalence of congenital heart anomalies is projected to rise significantly, especially in the 0−4 age group, while mortality rates are expected to continue a slow downward trend, particularly in the 20−69 age group.…”

Data Sheet 1_Global, regional, and national burdens of congenital heart anomalies from 1990 to 2021, and projections to 2050.pdf by Erdengqieqieke Ye (19542808)

“…Correlation analysis revealed increasing trends of prevalence and YLDs with rising SDI, while incidence, deaths, DALYs, and YLLs demonstrated a declining trend with SDI elevation. From 2022 to 2050, the prevalence of congenital heart anomalies is projected to rise significantly, especially in the 0−4 age group, while mortality rates are expected to continue a slow downward trend, particularly in the 20−69 age group.…”

Data Sheet 11_Global, regional, and national burdens of congenital heart anomalies from 1990 to 2021, and projections to 2050.pdf by Erdengqieqieke Ye (19542808)

“…Correlation analysis revealed increasing trends of prevalence and YLDs with rising SDI, while incidence, deaths, DALYs, and YLLs demonstrated a declining trend with SDI elevation. From 2022 to 2050, the prevalence of congenital heart anomalies is projected to rise significantly, especially in the 0−4 age group, while mortality rates are expected to continue a slow downward trend, particularly in the 20−69 age group.…”

Supplementary file 1_Global, regional, and national burdens of congenital heart anomalies from 1990 to 2021, and projections to 2050.xlsx by Erdengqieqieke Ye (19542808)

“…Correlation analysis revealed increasing trends of prevalence and YLDs with rising SDI, while incidence, deaths, DALYs, and YLLs demonstrated a declining trend with SDI elevation. From 2022 to 2050, the prevalence of congenital heart anomalies is projected to rise significantly, especially in the 0−4 age group, while mortality rates are expected to continue a slow downward trend, particularly in the 20−69 age group.…”

Data Sheet 4_Global, regional, and national burdens of congenital heart anomalies from 1990 to 2021, and projections to 2050.pdf by Erdengqieqieke Ye (19542808)

“…Correlation analysis revealed increasing trends of prevalence and YLDs with rising SDI, while incidence, deaths, DALYs, and YLLs demonstrated a declining trend with SDI elevation. From 2022 to 2050, the prevalence of congenital heart anomalies is projected to rise significantly, especially in the 0−4 age group, while mortality rates are expected to continue a slow downward trend, particularly in the 20−69 age group.…”

Data Sheet 7_Global, regional, and national burdens of congenital heart anomalies from 1990 to 2021, and projections to 2050.pdf by Erdengqieqieke Ye (19542808)

“…Correlation analysis revealed increasing trends of prevalence and YLDs with rising SDI, while incidence, deaths, DALYs, and YLLs demonstrated a declining trend with SDI elevation. From 2022 to 2050, the prevalence of congenital heart anomalies is projected to rise significantly, especially in the 0−4 age group, while mortality rates are expected to continue a slow downward trend, particularly in the 20−69 age group.…”